FIG. 1. The sites of action of TFPI and TAFI in the coagulation cascade are shown. TFPI inhibits VIIa and tissue factor; on the other hand, TAFI inhibits the conversion of fibrin and crossed-linked fibrin into soluble products.
Thrombin activatable fibrinolysis inhibitor (TAFI) (1, 2) is the zymogen that upon activation promotes the transformation of fibrin (clot) to become resistant to lysis (3) . This activity is mediated by TAFI's ability to eliminate the binding sites for plasminogen on partially digested fibrin, thus inhibiting plasminogen activation and fibrinolysis.
The activation of the coagulation pathway is a well known phenomenon in sepsis where TAFI and TFPI play regulatory functions ( Fig. 1 ). Alterations in highly regulated interactions be-tween endothelium and blood cells lead to a procoagulant state. Normally, the procoagulant pathway is balanced by anticoagulant factors such as protein C (PC), anti-thrombin (AT), tissue factor pathway inhibitor (TFPI), and the fibrinolytic system. Endothelial thrombomodulin (TM) binds to thrombin to activate PC, resulting in fibrinolysis via TAFI. Thrombin-TM links coagulation and the fibrinolytic system via the TAFI and protein C pathway. Elevated thrombin, reduced inhibition of thrombin by APC in sepsis tips the scale in favor of procoagulant activity by promoting TAFI activation into TAFIa, leading to a deficit in fibrinolysis (4) .
Tissue factor pathway inhibitor (TFPI) is a serpin of FVIIa-TF, and Xa (extrinsic pathway) (5) . TFPI is synthesized in the endothelium, stored in platelets and released by thrombin, shear stress, and drugs such as heparin. Severe disseminated intravascular coagulation (DIC) is associated with elevated TFPI (6) . Summary: Burn and septic injuries induce profound changes in coagulation status. This study examined the changes in plasma tissue factor pathway inhibitor (TFPI) and thrombin activatable fibrinolytic inhibitor (TAFI) levels in a rat model of burn and septic injuries. Rats underwent 30% TBSA cutaneous scald burn injury and septic insult was induced by caecal ligation and puncture (CLP). CLP was superimposed on burn injury to mimic the clinical model of sepsis complicating burn injury. Rats were pretreated with Cprofloxacin orally to colonize their gut with Enterococcus faecalis. TFPI and TAFI plasma levels were measured using functional activity assay kit with a chro-mogenic method at 24 and 72 hours following the injuries. TFPI levels decreased significantly at 24 hours in burn, CLP, and burn+CLP groups, followed by incomplete rebound recovery at 72 hours in all three groups. On the other hand, TAFI levels increased significantly at 24-and 72-hour time points in all three groups. These results suggest that burn, septic, and their combined injuries perturb coagulation cascade and thrombotic process toward the procoagulant pathway by impairing fibrinolysis. Key Words: Fibrinolysis-Caecal ligation and puncture-Disseminated intravascular coagulation-Gram-positive infection.
We hypothesized that burn and sepsis individually or in combination promote thrombogenesis, which may be associated with downregulation of TFPI and upregulation of TAFI.
MATERIALS AND METHODS

Animal Model
Male Sprague-Dawley rats weighing 250 to 275 g were divided into four groups consisting of sham, burn, CLP, and burn plus CLP. All rats received an intra-gastric lavage of Ciprofloxacin at the dose of 14 mg/kg per day for 3 days to colonize the gut with gram-positive Enterococcus faecalis. Burn and/or CLP were carried out under pentobarbital anesthesia. Burn rats were subjected to a full-thickness cutaneous scald burn of 30% total body surface area (TBSA). Burn rats were resuscitated with normal saline administered intraperitoneally. The cecum was ligated and a single puncture was made with a 22g needle with expression of colonic contents. The abdominal wound was closed in layers. The animals were sacrificed 1 or 3 days following the procedure. Blood samples were collected via cardiac puncture into siliconized glass tubes containing 3.8% sodium citrate. Blood was centrifuged at 2500g to obtain plasma samples that were frozen in batches until use. Plasma samples were analyzed for TAFI and TFPI activities.
TAFI Functional Activity Assay
TAFI was measured using a TAFI activity assay kit (Actichrome, American Diagnostica, Greenwich, CT). The procedure involves chromogenic assay that measures the carboxypeptidase activity of TAFI in plasma and biologic samples using a high-affinity substrate and color development system (7) . Plasma was incubated for 20 minutes with 15 µL of TAFI activation reagent containing thrombin-thrombomodulin complex that converts the proenzyme TAFI to its activated form, TAFIa. The activation was arrested with 15 µL of activation stop reagent. Plasma samples were assayed subsequently for total carboxypeptidase (CP) activity by incubating for 30 minutes with 50 µL of TAFI developer containing a substrate and color development system. The sample was assayed for CPN activity by incubating with TAFI developer and 25 µL of potato tuber carboxypeptidase (PTCI) inhibitor (PTCI), which inhibits TAFIa activity but not CPN. Fifty microliters of 2M sulfuric acid was used to stop the enzymatic reaction and absorbance of the solution was read at 490 nm using spectrophotometry. The difference in the absorbance was calculated and the TAFIa values were extrapolated from TAFIa standard curve. This difference in carboxypeptidase activity between samples with and without PTCI represents the amount of TAFI activity in the samples.
TFPI Activity Assay
TFPI activity was measured by using a functional method assay kit (Actichrome, American Diagnostica, Greenwich, CT). The principle of the method involves the ability of TFPI to inhibit the catalytic activity of the TF/FV11a complex to activate factor X to factor Xa. After incubation of plasma with TF/FV11a and FX, the residual activity of the TF/V11a complex is measured using spectrozyme FXa, a highly specific chromogenic substrate cleaved only by FXa generated in the assay, releasing a p-nitroanilline (pNA) chromophore. The absorbance of the pNA in the reaction solution at 405 nm is measured and compared to those values obtained from a standard curve constructed using known TFPI activity levels (8) .
Statistical Analysis
All values are reported as mean ± SEM. Oneway analysis of variance was used for group comparisons. Multiple comparisons were performed using Bonferroni's correction. Fig. 2 shows a comparison of functional TFPI levels in burn, CLP, and burn+CLP groups of rats at 24 hours in contrast with sham. Both the burn and CLP insults significantly decreased TFPI levels at 24 hours. The burn+CLP group exhibited a much more significant reduced response com-FIG. 2. TFPI activity in plasma at 24 hours was measured using a functional method assay kit. The method is based on the ability of TFPI to inhibit the catalytic activity of the TF/FVIIa complex to activate factor X to factor Xa. Bars representing all groups show mean±SE. Values were obtained from six animals. *p<0.05 sham vs. burn, CLP, and burn+CLP. † p<0.05 burn+CLP vs. burn, and CLP.
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pared to burn and CLP, suggesting that the combined injury produced a stronger decline in TFPI plasma level. Fig. 3 illustrates changes in plasma TFPI levels at 72 hours in the three representative groups. A similar significant trend in the reduction of TFPI was noted in burn, CLP, and burn+CLP. No significant differences existed between burn day 1 versus burn day 3 and burn+CLP day 1 versus burn+CLP day 3. The relative reduction in comparison to the 24-hour group was weaker. Fig. 4 represents the functional plasma TAFI levels in the three groups at 24 hours. It is evident that a significant increase in functional TAFI level was observed in all three groups. No differences were noted between burn, CLP, and burn+CLP groups. Fig. 5 demonstrates change in functional plasma TAFI level at 72 hours. All three groups showed a marked significant increase in TAFI level in comparison to results at 24 hours. The relative increase however was much more dramatic in the burn group. A significant difference between burn and CLP was noted; however, burn and burn+CLP were not different.
DISCUSSION
Tissue factor pathway activation in burn and sepsis contribute significantly to the observed thrombogenesis in patients (4, 9) . Similarly in burn injury, the massive release of tissue factor from various sites contribute to thrombotic complications. TFPI represents a kunitz type serine protease inhibitor, which plays an important role in the control of tissue factor (5) and is synthesized by the endothelial cells. TFPI controls tissue factor-FVIIa activity (10, 11) . TFPI gene deletion in mice leads to severe thrombotic complications (12) . TFPI, a natural anticoagulant, possesses anti-inflammatory properties (13) . The majority of TFPI is associated with lipoprotein on the cell membrane (14) .
In our study, we demonstrated that burn and sepsis results in downregulation of the functional levels of TFPI. In groups where both insults were combined, the decrease in TFPI plasma level was much greater. The addition of grampositive infection to burn injury resulted in a greater suppression in TFPI level, suggesting a greater sensitivity of anti-coagulant pathway to µg/mL µg/mL burn+CLP injury. Time-dependent recovery/rebound of TFPI was seen in all three groups. However, the levels remain reduced, indicating the sustained consumption of this inhibitor. The recovery appeared to be better in burn injury, whereas it was much slower in CLP, and burn+CLP groups. It appears that infection may play a role in slowing the rebound/recovery of TFPI plasma levels. Many studies showed depletion of TFPI in sepsis (15) . An elevated level of TFPI was associated with non-survival in some studies (16) .
An upregulation of TAFI was suggestive of a fibrinolytic deficit after burn, CLP, and burn+CLP. Unlike the TFPI levels, an augmented reduction of TAFI was not seen in those animals challenged with burn+CLP. Furthermore, a marked increase was seen in the TAFI levels at 72 hours in all three groups. Thus, there is a clearcut difference between the regulation of TAFI and TFPI in septic and burn injured animals. This is further reinforced by a lack of correlation between the two mediators. Burn injury by itself produced a fibrinolytic deficit that was greater than CLP and burn+CLP, suggesting that added infection to burn injury had no additive effect on TAFI level. TAFI has been shown to inactivate C5a. Thrombin-TM complex clears activated TAFI and thus protects the microvasculature (17) . On the other hand, inflammation downregulates TM; a decrease in TAFI activation and increased complement activation could work together to produce injury to the vessel wall and expose coagulant phospholipids surfaces. The thrombin-thrombomodulin complex forms a molecular link between fibrinolytic and coagulation cascades via TAFI. In sepsis, increased thrombin and reduced APC inhibition of thrombin generation promotes TAFI resulting in inhibition of fibrinolysis (18) . The pathway of both the burn and septic injury leading to thrombogenesis and DIC is complex and not fully understood. The fact that a consumption of TFPI is observed in both syndromes clearly points to pro-thrombotic events. The sustained upregulation of TAFI without any rebound and recovery in both groups is suggestive of thrombotic complications, which requires further elucidation. All three groups of rats were pre-treated with Ciprofloxacin to exclude the contribution of gram-negative bacteria and hence this model portrays gram-positive (E. faecalis) sepsis. SUMMARY 1. Burn, sepsis and their combined insult results in activation of coagulation, leading to the consumption of TFPI.
2. Similarly in these groups of rats an increased TAFI level is highly suggestive of fibrinolytic deficit, which may augment the thrombotic response.
3. The relatively higher levels in TAFI and the non-rebound recovery response in TFPI may be related to the pre-treatment of these rats with Ciprofloxacin.
CONCLUSIONS
The hemostasis abnormalities in burn and sepsis are demonstrated to be associated with increase in thrombogenesis and decrease in fibrinolysis. The measurements of TFPI and TAFI in this model provide additional insights into the pathogenesis of burn and sepsis, which not only help in diagnosis, but also in determining treatment modalities.
